Zenotech Laboratories Ltd. (ZENOTECH)
Market Closed
11 Aug, 22:00
MSE MSE Primary ₹
44. 75
+0.25
+0.5618%
₹
2.34B Market Cap
38.87 P/E Ratio
- Div Yield
76 Volume
0 Eps
₹ 44.5
Previous Close Want to track ZENOTECH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ZENOTECH closed today higher at ₹44.75, an increase of 0.5618% from yesterday's close, completing a monthly increase of 1.7045% or ₹0.75. Over the past 12 months, ZENOTECH stock lost -4.767%.
ZENOTECH is not paying dividends to its shareholders.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.1052%, based on the last three reports.
Zenotech Laboratories Ltd. has completed 1 stock splits, with the recent split occurring on Jun 01, 2017.
The company's stock is traded on one exchange.
Zenotech Laboratories Ltd. (ZENOTECH) FAQ
What is the stock price today?
The current price is ₹44.75.
On which exchange is it traded?
Zenotech Laboratories Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is ZENOTECH.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 2.34B.
Has Zenotech Laboratories Ltd. ever had a stock split?
Zenotech Laboratories Ltd. had 1 splits and the recent split was on Jun 01, 2017.
Zenotech Laboratories Ltd. Profile
| Biotechnology Industry | Healthcare Sector | - CEO | MSE Exchange | INE486F01012 ISIN |
| India Country | 228 Employees | - Last Dividend | - Last Split | - IPO Date |
Zenotech Laboratories Ltd. is a pharmaceutical company engaged in the research, development, and manufacturing of generic pharmaceuticals. Its primary purpose is to provide affordable and high-quality generic medication to a global market, focusing on oncology and general pharmaceutical injectables. With a significant emphasis on catering to critical health care needs, Zenotech Laboratories operates in sectors crucial to public health and medical treatment. The company's production capabilities include state-of-the-art facilities that adhere to stringent regulatory standards, making it a key player in the pharmaceutical manufacturing industry. Zenotech's role in the market is bolstered by its commitment to sustainable practices and innovative methodologies, addressing both domestic and international pharmaceutical needs. By fostering strong partnerships and investing in advanced technologies, the company plays a pivotal role in driving the availability of life-saving drugs and contributing substantially to the global healthcare landscape.
Contact Information
Address: Survey No. 250-252
Phone: 91 90 3204 4584
Website: https://zenotechlab.com
